Opko Health Inc (OPK) concluded trading on Thursday at a closing price of $1.82, with 3.63 million shares of worth about $6.61 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.64% during that period and on March 20, 2025 the price saw a loss of about -2.15%. Currently the company’s common shares owned by public are about 671.55M shares, out of which, 303.61M shares are available for trading.
Stock saw a price change of 5.81% in past 5 days and over the past one month there was a price change of 6.43%. Year-to-date (YTD), OPK shares are showing a performance of 23.81% which increased to 110.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.87 but also hit the highest price of $2.04 during that period. The average intraday trading volume for Opko Health Inc shares is 4.74 million. The stock is currently trading 2.16% above its 20-day simple moving average (SMA20), while that difference is up 10.76% for SMA50 and it goes to 19.73% higher than SMA200.
Opko Health Inc (NASDAQ: OPK) currently have 671.55M outstanding shares and institutions hold larger chunk of about 31.33% of that.
The stock has a current market capitalization of $1.22B and its 3Y-monthly beta is at 1.75. It has posted earnings per share of -$0.09 in the same period. It has Quick Ratio of 3.13 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OPK, volatility over the week remained 4.06% while standing at 5.29% over the month.
Stock’s fiscal year EPS is expected to drop by -291.67% while it is estimated to increase by 25.96% in next year. EPS is likely to shrink at an annualized rate of -11.20% for next 5-years, compared to annual growth of 32.04% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barrington Research on June 29, 2023 offering an Outperform rating for the stock and assigned a target price of $2 to it. Coverage by H.C. Wainwright stated Opko Health Inc (OPK) stock as a Buy in their note to investors on December 15, 2022, suggesting a price target of $3 for the stock. On January 24, 2022, Barrington Research Downgrade their recommendations, while on June 21, 2021, Ladenburg Thalmann Initiated their ratings for the stock with a price target of $7. Stock get an Overweight rating from Piper Jaffray on November 25, 2019.
